lenalidomide has been researched along with Melena in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hashmi, H; Maghavani, DP; Reynolds, SB | 1 |
| Brouwer, RE; Heidt, J; Langers, AM; van der Meer, FJ | 1 |
2 other study(ies) available for lenalidomide and Melena
| Article | Year |
|---|---|
Acquired factor X deficiency in a patient with multiple myeloma: a rare case highlighting the significance of comprehensive evaluation and the need for antimyeloma therapy for bleeding diathesis.
Topics: Anti-Inflammatory Agents; Antineoplastic Agents; Bortezomib; Combined Modality Therapy; Dexamethasone; Diagnosis, Differential; Factor X Deficiency; Humans; Immunologic Factors; Lenalidomide; Male; Melena; Middle Aged; Multiple Myeloma; Stem Cell Transplantation | 2019 |
Thalidomide as treatment for digestive tract angiodysplasias.
Topics: Aged, 80 and over; Angiodysplasia; Gastrointestinal Diseases; Gastrointestinal Hemorrhage; Humans; Lenalidomide; Male; Melena; Recurrence; Thalidomide; Treatment Outcome; von Willebrand Diseases | 2006 |